Comparison

CMPD101 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 100 mg
Item no. HY-103045-100mg
CASRN 865608-11-3
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
CMPD101 is a potent, highly selective and membrane-permeable small-molecule inhibitor of GRK2/3 with IC50 of 18 nM and 5.4 nM, respectively. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1 μM , 2.3 μM, 1.4 μM and 8.1 μM, respectively. CMPD101 can be used for the study of heart failure[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
Manufacturers Applications
COVID-19-anti-virus
MolecularWeight
466.46
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cardiovascular Disease
Solubility
DMSO : 250 mg/mL (ultrasonic)
Manufacturers Target
PKC; ROCK
Isoform
PKCα; ROCK2
Pathway
Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Stem Cell/Wnt; TGF-beta/Smad
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close